Literature DB >> 24532810

Planning deficit in children with neurofibromatosis type 1: a neurocognitive trait independent from attention-deficit hyperactivity disorder (ADHD)?

Cinzia Galasso1, Adriana Lo-Castro2, Loredana Di Carlo1, Maria Bernarda Pitzianti1, Elisa D'Agati1, Paolo Curatolo1, Augusto Pasini1.   

Abstract

Neurofibromatosis type 1 is associated with executive dysfunctions and comorbidity with attention-deficit hyperactivity disorder (ADHD) in 30% to 50% of children. This study was designed to clarify the neurocognitive phenotype observed in neurofibromatosis type 1 by testing the hypothesis that children with neurofibromatosis type 1 have specific planning deficits independently from intellectual level and ADHD comorbidity. Eighteen children with neurofibromatosis type 1 were pair-matched to 18 children with ADHD and 18 healthy controls. All groups were assessed on the presence of ADHD symptoms (Conners Scales) and planning deficits (Tower of London). Compared with control group, groups with neurofibromatosis type 1 and ADHD demonstrated significant impairment of planning and problem solving. The lack of correlation between Tower of London results and Conners subscale scores in neurofibromatosis type 1 group confirmed that the planning and problem-solving deficit is not directly related to inattention level. These findings suggested that the executive impairment probably represents a peculiar trait of neurofibromatosis type 1 neurocognitive phenotype.
© The Author(s) 2014.

Entities:  

Keywords:  Tower of London; attention-deficit hyperactivity disorder (ADHD); executive functions; neurofibromatosis type 1; planning

Mesh:

Year:  2014        PMID: 24532810     DOI: 10.1177/0883073813517001

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

Review 1.  A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.

Authors:  Andrew J D Crow; Jennica M Janssen; Carolina Marshall; Anne Moffit; Laura Brennan; Christian G Kohler; David R Roalf; Paul J Moberg
Journal:  Am J Med Genet A       Date:  2022-05-12       Impact factor: 2.578

Review 2.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

3.  Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.

Authors:  Magdalena Heimgärtner; Sofia Granström; Karin Haas-Lude; Robert A Leark; Victor-Felix Mautner; Karen Lidzba
Journal:  Int J Pediatr       Date:  2019-12-10

4.  [Clinical aspects of Neurofibromatosis type 1 seen in the Department of Dermatology at University Hospital Antananarivo, Madagascar].

Authors:  Fandresena Arilala Sendrasoa; Aurélie Rasoarisata; Lala Soavina Ramarozatovo; Fahafahantsoa Rapelanoro Rabenja
Journal:  Med Trop Sante Int       Date:  2022-05-27

5.  Cognitive and Electrophysiological Correlates of Working Memory Impairments in Neurofibromatosis Type 1.

Authors:  Gorana Pobric; Jason R Taylor; Hemavathy M Ramalingam; Emily Pye; Louise Robinson; Grace Vassallo; JeYoung Jung; Misty Bhandary; Karolina Szumanska-Ryt; Louise Theodosiou; D Gareth Evans; Judith Eelloo; Emma Burkitt-Wright; Johan Hulleman; Jonathan Green; Shruti Garg
Journal:  J Autism Dev Disord       Date:  2021-05-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.